Letrozole DOSAGE,Raw Material Provider,Medicine Results,side effects information

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

a white solid with madicaion

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Letrozole Manufacturers in India Suppliers Letrozole Dossage Exporters Distributors Letrozole api active pharmaceuticals ingredients Letrozole manufacturers Side Effects bulk drugs raw material Dossage Letrozole companies Side Effects Dossage Importers Letrozole Dossage Letrozole Exporters Letrozole exporters Dossage FDA Dossage Letrozole Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Letrozole manufacturing pharmaceutical drugs pharmaceutical intermediates Letrozole pharmaceutical chemicals pharmaceutical raw materials Letrozole active pharmaceutical ingredients Letrozole committee active pharmaceutical ingredients manufacturer Letrozole Active Pharmaceutical Ingredients manufacturer Letrozole exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Letrozole, Letrozole manufacturer India, Letrozole product, Letrozole products, Api preparation, Certificate of Analysis API manufacturer product, Letrozole anti ulcer product, Certificate of Origin COA Letrozole COS Letrozole, pharmaceutical generic, pharmaceutical drug, medical, Letrozole pharma healthcare, pharma patents, contract MSDS manufacturing Trader Letrozole pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Letrozole expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Letrozole DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Letrozole ingredients, api, HIV Letrozole, tablets, capsules, syrup & protein Letrozole powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Letrozole gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Letrozole WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

taj pharma Letrozole

HOME >> API >> API List 2 >> Letrozole >> Dosage

DOSAGE
Letrozole CAS Registry Number 112809-51-5

The recommended dose of ® (letrozole tablets) is one 2.5 mg tablet administered once a day, without regard to meals. In patients with advanced disease, treatment with should continue until tumor progression is evident.

In the extended adjuvant setting, the optimal treatment duration with is not known. The planned duration of treatment in the study was 5 years. However, at the time of the analysis, the median treatment duration was 24 months, 25% of patients were treated for at least 3 years and less than 1% of patients were treated for the planned duration of 5 years. The median duration of follow-up was 28 months. Treatment should be discontinued at tumor relapse
In the adjuvant setting, the optimal duration of treatment with letrozole is unknown. The planned duration of treatment in the study is 5 years. However, at the time of analysis, the median duration of treatment was 24 months, median duration of follow-up was 26 months, and 16% of the patients have been treated for 5 yearsNo dose adjustment is required for elderly patients. Patients treated with do not require glucocorticoid or mineralocorticoid replacement therapy.o dose adjustment is required for elderly patients. Patients treated with do not require glucocorticoid or mineralocorticoid replacement

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE >>

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin	Gemcitabine Hcl	Glimepiride	Granisetron Hcl	Ibandronate Sodium	Imatinib Mesylate	Irbesartan	Irinotecan Hcl	Isradipine	Lamotrigine
Lercanidipine	Letrozole	Losartan Potassium	Loteprednol Etabonate	Magnesium Valproate	Meloxicam	Memantine Hcl	Mesalazine	Metamizol Magnesium	Metaxalone
Metformin Hcl	Metoprolol Tartrate	Mifepristone	Mirtazapine	Modafinil	Mometasone Furoate	Naltrexone Hcl	Netaglinide

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.